한글목차

세계의 세포 투과성 펩티드 시장은 2025년에는 42억 달러에 달하고, 2032년에는 121억 6,000만 달러에 이를 것으로 예측되고, 2025년부터 2032년까지의 CAGR은 16.4%를 나타낼 것으로 전망됩니다.

그림. 세포 투과성 펩티드 시장 점유율(%), 지역별(2025년)

세포 투과성 펩티드(CPP)는 세포막을 통과하여 항체, 핵산, 화학치료제 등의 생물활성물질을 세포내에 전달할 수 있는 짧은 아미노산 서열입니다. 효율성 등의 약리학적 특성을 개선하기 위해 세포 투과성 펩티드(CPPs)의 서열과 컨쥬게이션 기술을 최적화하는 연구가 활발히 이루어지고 있습니다.

CPP는 생리적 조건 하에서 생세포에 비침습적, 효율적, 신속하게 카고 분자를 전달하기 때문에 종래의 트랜스펙션법에는 없는 수많은 이점을 제공합니다. 전자 도입, 영상 진단 등의 연구·치료 용도에 큰 가능성을 지니고 있습니다. 그러나 그 비선택적인 이중층 파괴와 고농도에서의 세포독성의 가능성은 여전히 큰 과제입니다.

시장 역학 :

세포 투과성 펩티드 시장은 치료제의 세포 내 전달을 필요로 하는 암 등의 질병 증가, 연구개발의 진전, 제약기업에 의한 투자, 펩티드 기반의 약제의 채용 확대 등이 견인하고 있습니다. 안정성이 낮고 예측할 수 없는 독성, 면역반응의 저해 등 과제가 시장 성장을 방해하고 있습니다.

본 조사의 주요 특징

• 본 보고서는 세계의 세포 투과성 펩티드 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
• 또한 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 파라미터를 바탕으로 세계의 세포 투과성 펩티드 시장 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 출시, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
• 이해관계자는 세계의 세포 투과성 펩티드 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• 일관된 기회 맵(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 서비스 제공 포트폴리오
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오
• 파이프라인 분석

제4장 세계의 세포 투과성 펩티드 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 세포 투과성 펩티드 시장, 유형별(2020-2032년)

• 단백질 유래 CPP
• 합성 CPP
• 키메릭 CPP

제6장 세계의 세포 투과성 펩티드 시장, 용도별(2020-2032년)

• 약물전달
• 유전자 전달
• 진단
• 분자 이미징
• 기타

제7장 세계의 세포 투과성 펩티드 시장, 최종 사용자별(2020-2032년)

• 바이오 제약 기업
• 임상시험수탁기관(CRO)/CDMO
• 병원 및 진료소
• 기타

제8장 세계의 세포 투과성 펩티드 시장, 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제9장 경쟁 구도

• AnaSpec
• Peptomyc
• BioAlps
• Sarepta Therapeutics, Inc.
• REVANCE THERAPEUTICS
• PolyPeptide Group
• Bachem
• Pepscan
• Creative Peptides
• Cupidpeptides
• AltaBioscience Ltd

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Global Cell Penetrating Peptide Market is estimated to be valued at USD 4.2 Bn in 2025 and is expected to reach USD 12.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.

Figure. Global Cell Penetrating Peptide Market Share (%), By Region 2025

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Key features of the study:

• This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

• Global Cell Penetrating Peptide Market, By Type
  • Protein Derived CPPs
  • Synthetic CPPs
  • Chimeric CPPs
• Global Cell Penetrating Peptide Market, By Application
  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others
• Global Cell Penetrating Peptide Market, By End User
  • Biopharmaceutical Companies
  • Contract Research Organization (CROs)/CDMO
  • Hospitals and Clinics
  • Others
• Global Cell Penetrating Peptide Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Cell Penetrating Peptide Market, By Type
  • Global Cell Penetrating Peptide Market, By Application
  • Global Cell Penetrating Peptide Market, By End User
  • Global Cell Penetrating Peptide Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Expanding Applications in Regenerative Medicine
  • Low drug encapsulation efficiency
  • Increasing applications of CPPs in therapeutics development
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Protein Derived CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Synthetic CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Chimeric CPPs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Gene Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Molecular Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organization (CROs)/CDMO
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• AnaSpec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Peptomyc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioAlps
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sarepta Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• REVANCE THERAPEUTICS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PolyPeptide Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
• Bachem
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pepscan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Peptides
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cupidpeptides
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AltaBioscience Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us